---
title: "The morning session of the 2025 National Conference opens: CR Sanjiu and YILING PHARMACEUTICAL enter the arena, negotiations on traditional Chinese medicine varieties begin"
description: "According to reporters from the on-site negotiations for the 2025 National Medical Insurance Directory and the price negotiations for innovative drugs with commercial insurance, the process for the fo"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263867464.md"
published_at: "2025-11-02T00:59:20.000Z"
---

# The morning session of the 2025 National Conference opens: CR Sanjiu and YILING PHARMACEUTICAL enter the arena, negotiations on traditional Chinese medicine varieties begin

> According to reporters from the on-site negotiations for the 2025 National Medical Insurance Directory and the price negotiations for innovative drugs with commercial insurance, the process for the fourth day of the 2025 national negotiations began around 8 a.m. Representatives from pharmaceutical companies such as CR Sanjiu, Jianmin Pharmaceutical, Beijing YILING PHARMACEUTICAL, Eisai, and Kereis Pharmaceuticals entered the venue in succession to await negotiations. Representatives from traditional Chinese medicine companies entered in large numbers, and negotiations for traditional Chinese medicine varieties are expected to begin

According to reporters from the 2025 National Medical Insurance Catalog on-site negotiations and commercial insurance innovative drug catalog price negotiations, the process of the fourth day of the 2025 national negotiations began around 8 a.m. Representatives from pharmaceutical companies such as CR Sanjiu, Jianmin Pharmaceutical, Beijing YILING PHARMACEUTICAL, Eisai, and Kereis Pharmaceutical entered the venue in turn to await negotiations. Representatives from traditional Chinese medicine companies entered in succession, and negotiations for traditional Chinese medicine varieties are expected to begin

### Related Stocks

- [002603.CN - YILING PHARMACEUTICAL](https://longbridge.com/en/quote/002603.CN.md)
- [000999.CN - CR Sanjiu](https://longbridge.com/en/quote/000999.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Yiling Pharmaceutical Unit Gets China Nod for Alzheimer's Drug Raw Material | Yiling Pharmaceutical Unit Gets China Nod for Alzheimer's Drug Raw Material | [Link](https://longbridge.com/en/news/265661137.md) |
| Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules | Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules | [Link](https://longbridge.com/en/news/267815314.md) |
| Vedanta says declared preferred bidder for Karnapodikonda bauxite block in Odisha | Vedanta says declared preferred bidder for Karnapodikonda bauxite block in Odisha | [Link](https://longbridge.com/en/news/277450980.md) |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, | [Link](https://longbridge.com/en/news/275124956.md) |
| SDI's Stock Pops as China's Sinocera Plans to Buy Australian Dental Materials Firm for USD110 Million | Shares of SDI surged over 45% to AUD1.28 after announcing its acquisition by China's Sinocera for AUD166 million (USD109 | [Link](https://longbridge.com/en/news/277428719.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.